<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04760912</url>
  </required_header>
  <id_info>
    <org_study_id>022</org_study_id>
    <nct_id>NCT04760912</nct_id>
  </id_info>
  <brief_title>General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery</brief_title>
  <official_title>Comparison of General Anesthesia With Use of Muscle Relaxation and General Anesthesia Without Muscle Relaxation on Recovery of Muscle Strength of the Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Centre Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Hospital Centre Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuromuscular blocking agents are often used during general anesthesia. Also, general&#xD;
      anesthesia may be performed without use of neuromuscular blocking agents.&#xD;
&#xD;
      Avoiding neuromuscular relaxation enables better muscle strength recovery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rocuronium is well used neuromuscular blocking agent during general anesthesia. Although very&#xD;
      often used, neuromuscular blocking agents may sometimes have consequence in form of residual&#xD;
      neuromuscular block.&#xD;
&#xD;
      Tha aim of the study is to compare influence of rocuronium during general anesthesia on&#xD;
      muscle strength recovery measured by hand grip dynamometer. Measuremwnt of hand grip strength&#xD;
      is perforrmed before and after general anesthesia. This research should contribute to better&#xD;
      choice of anesthesia technique and better quality of patient recovery, as studies so far have&#xD;
      not been detaily carried out.&#xD;
&#xD;
      Hypothesis of the research is that anesthesia without use of neuromuscular blocking agents&#xD;
      may enable better recovery of muscle strength in immediate postoperative period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle strenght recovery after general anesthesia</measure>
    <time_frame>Perioperative</time_frame>
    <description>Change in muscle strength recovery measured with hand grip dynamometer after general anesthesia with or without rocuronium. Better understanding of mechanism how neuromuscular blockade influences quality if patient recovery due to muscle strength recovery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Rocuronium</condition>
  <condition>Muscle Weakness</condition>
  <condition>General Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Experimental group general anesthesia without rocuronium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patient ASA classification 1-2 for general anesthesia. Standard anesthesia monitoring. After induction with Propofol and Sufentanil ( doses adjusted according to weight and age) anesthesia was maintained with sevorane. Muscle strength measured on three occasions with Yamar dinamometar for hand grip strength, before induciran to anesthesia and immediate after Salingeru from anesthesia, then again measured in first 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active comparator: general anesthesia with rocuronium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 patient ASA classification 1-2 for general anesthesia. Standard anesthesia monitoring with train-of-four (TOF). After induction with Propofol and Sufentanil (doses adjusted according to weight and age) and rocuronium 0,6 mg per kg, anesthesia maintained with sevorane. Muscle strength neasured with Yamar dinamometar for hand grip strength before induction to anesthesia and immediate after awakening from anesthesia, then again measured in first 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Rocuronium used for neuromuscular blokade during anesthesia and anesthesia without rocuronium</description>
    <arm_group_label>Active comparator: general anesthesia with rocuronium</arm_group_label>
    <other_name>Rocuronium bromide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia for surgery</intervention_name>
    <description>General anesthesia with standard anesthetic monitoring,</description>
    <arm_group_label>Active comparator: general anesthesia with rocuronium</arm_group_label>
    <arm_group_label>Experimental group general anesthesia without rocuronium</arm_group_label>
    <other_name>General anesthesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients ASA status I-III for surgery under general anesthesia&#xD;
&#xD;
          -  signed informed consent for participating in research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  neuromuscular disease&#xD;
&#xD;
          -  poorly controled chronic or acute cardiovascular, respiratory or autoimmune disease&#xD;
&#xD;
          -  known allergic reaction to any medication used in this research&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  refusal to participate in this research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UHCZagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Bowman WC. The neuromuscular junction: recent developments. Eur J Anaesthesiol. 1985 Mar;2(1):59-93. Review.</citation>
    <PMID>2410263</PMID>
  </reference>
  <reference>
    <citation>GÃ¤tke MR, Viby-Mogensen J, Rosenstock C, Jensen FS, Skovgaard LT. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand. 2002 Feb;46(2):207-13.</citation>
    <PMID>11942873</PMID>
  </reference>
  <reference>
    <citation>Fuchs-Buder T, Schmartz D. [Residual neuromuscular blockade]. Anaesthesist. 2017 Jun;66(6):465-476. doi: 10.1007/s00101-017-0325-1. Review. German. Erratum in: Anaesthesist. 2017 Aug;66(8):578.</citation>
    <PMID>28573344</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Centre Zagreb</investigator_affiliation>
    <investigator_full_name>Martina Miklic Bublic, MD, PhD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Rocuronium</keyword>
  <keyword>Muscle strength</keyword>
  <keyword>Residual blockade</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

